The infection is sexually transmitted and is believed to facilitate HIV transmission. Trials were also identified from reference lists of reviews, through pharmaceutical companies, and by informal discovery. Only published data were used in this review. Different antitrichomonal drugs or doses were eligible, as were comparisons of treatment with no treatment or placebo. Trial quality was assessed and data extracted by two reviewers independently using standard criteria.
Nitroimidazole drugs seem to be effective in achieving parasitological cure in short term follow up.
Partner treatment can be effective in decreasing longer term reinfection rates. Further research should focus on developing effective partner treatment strategies to prevent reinfections and reduce trichomoniasis prevalence. This is an abstract of a regularly updated, systematic review prepared and maintained by the Cochrane Collaboration. Update Software Ltd. All rights reserved.